Foresite Capital Management IV LLC

Foresite Capital Management IV LLC latest Q4_2020 13F filings reported $920,621,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 107.60%. This fund has 13 securities concentrations of 100% weights.

Foresite Capital Management IV LLC largest holding is Kinnate Biopharma Inc. with weight of 41.79% and $384,738,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR13$920,621,000107.60%
2020-11-132020-09-30Q3_202013F-HR15$443,450,000116.02%
2020-08-132020-06-30Q2_202013F-HR12$205,283,000153.01%
2020-05-282020-03-31Q1_202013F-HR/A11$81,136,0000.00%
2020-05-142020-03-31Q1_202013F-HR11$81,136,000-64.99%
2020-02-142019-12-31Q4_201913F-HR14$231,764,000-24.15%
2019-11-132019-09-30Q3_201913F-HR17$305,570,000-12.16%
2019-08-132019-06-30Q2_201913F-HR20$347,852,00025.01%
2019-05-142019-03-31Q1_201913F-HR16$278,257,00027.72%
2019-02-132018-12-31Q4_201813F-HR18$217,868,000-28.57%
2018-11-132018-09-30Q3_201813F-HR21$305,020,0005.97%
2018-08-142018-06-30Q2_201813F-HR16$287,838,00029.90%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
KINNATE BIOPHARMA INCKNTEBUY$384,7380.00%41.79%$39.780.00%9,671,643
KEROS THERAPEUTICS INCKROSINCR$99,65282.89%10.82%$70.54-100.00%1,412,705
RELAY THERAPEUTICS INCRLAYDECR$88,913-2.42%9.66%$41.560.00%2,139,380
ALX ONCOLOGY HLDGS INCALXOINCR$83,917128.41%9.12%$86.20-100.00%973,514
NURIX THERAPEUTICS INCNRIXDECR$77,196-5.82%8.39%$32.88-100.01%2,347,804
KURA ONCOLOGY INCKURAINCR$59,04947.34%6.41%$32.66-61.77%1,807,982
OLEMA PHARMACEUTICALS INCOLMABUY$39,3310.00%4.27%$48.080.00%818,030
CYTOKINETICS CYTKDECR$29,840-17.58%3.24%$20.78-114.13%1,435,992
GENERATION BIO COGBIODECR$24,323-8.28%2.64%$28.350.00%857,939
VAXCYTE INCPCVXDECR$12,377-46.19%1.34%$26.570.00%465,821
CYMABAY THERAPEUTICS INCCBAYDECR$10,258-20.72%1.11%$5.740.00%1,787,094
ACLARIS THERAPEUTICS INCACRSINCR$6,1551554.57%0.67%$6.47456.70%951,384
THERAPEUTICS ACQUISITION CORRACADECR$4,872-3.20%0.53%$13.920.00%350,000
ARBUTUS BIOPHARMA CORPABUSSOLD$00.00%-100.00%$0.000.00%0
MYOKARDIA INCMYOKSOLD$00.00%-100.00%$0.000.00%0
PANACEA ACQUISITION CORPSOLD$00.00%-100.00%$0.000.00%0
VOYAGER THERAPEUTICS INCVYGRSOLD$00.00%-100.00%$0.000.00%0